Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950135-07-000691
Filing Date
2007-02-12
Accepted
2007-02-12 16:09:17
Documents
1
Group Members
ATLAS VENTURE ASSOCIATES V, INC.ATLAS VENTURE ASSOCIATES V, L.P.ATLAS VENTURE ASSOCIATES VI, INC.ATLAS VENTURE ASSOCIATES VI, L.P.ATLAS VENTURE ENTREPRENEURS' FUND V, L.P.ATLAS VENTURE ENTREPRENEURS' FUND VI, L.P.ATLAS VENTURE FUND VI GMBH & CO. KGATLAS V

Document Format Files

Seq Description Document Type Size
1 ATLAS VENTURE FUND V, L.P. b64030alsc13gza.htm SC 13G/A 76057
  Complete submission text file 0000950135-07-000691.txt   78406
Mailing Address
Business Address 222 BERKELEY ST BOSTON MA 02116 6178599290
ATLAS VENTURE FUND V LP (Filed by) CIK: 0001106910 (see all company filings)

EIN.: 043500803 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Subject) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-79884 | Film No.: 07603133
SIC: 2834 Pharmaceutical Preparations